
Sign up to save your podcasts
Or


Learning which antibiotics treat which bacteria and how to dose those antibiotics is like trying to learn a foreign language. Words sound weird and are difficult to pronounce. At first, nothing really makes any sense and what we all need is more practice. In this episode, we'll start talking about some of the basics. Just like in previous episodes we'll use concrete examples to support the points that we make. One 16 minute podcast wont make you an expert at bugs and drugs but we can begin to lay an important foundation that we can build upon in future episodes. So join me as we work on the foreign language that we call "Bugs and Drugs."
In this second part of a 2-part episode on Correlation vs. Causation, we explore two relevant examples of where someone got it exactly wrong. Often times, the lay press and media coverage - especially social media coverage - make it difficult to figure out what's really going on. It's not our fault when social media gets something wrong but we do have control over how we react to it. As Dr. Daniel Kahneman describes, "fast thinking" about what we see and read isn't very helpful but it is very prevalent. In this episode, we'll slow down, carefully consider our examples and discuss what is really going on.
Understanding correlation versus causation is important. It is important in clinical drug trials and it is important in making public policy. If we dont really understand what the underlying cause of a problem is, we cannot fix that problem. In this 2-part episode, we'll explore this concept a bit and use relevant examples to highlight what is correlated and what is truly cause-and-effect.
Humans are very good at recognizing associations. It's hard wired into us. We do it all the time in our daily life and clinical trialists also have to do it in drug trials. The concept is easy. But it remains surprisingly difficult to separate one from the other. Fortunately for us, many lessons have been learned. In this episode, we use both medical and non-medical examples to discuss correlation vs. causation and to lay some groundwork for our future discussions of drug therapy.
In this second part of our 2 part series on aspirin, we focus in on what aspirin does and what both the FDA and clinical guidelines say about who should take it for primary prevention. Then, to make sense of the conflicting advice, we briefly discuss the clinical trials themselves so we can make up our own minds about "Who should take a daily aspirin?"
Aspirin is complicated. Advice on who should take it is conflicting and always changing. In this 2-part episode we'll explore why that is. We'll learn a bit about atherosclerosis - the disease that aspirin can treat. We'll explore what the FDA says about aspirin and what as well as what is recommended by a couple of the commonly used guidelines. Last, we'll summarize what was found in the clinical trials and how those finding led to some much conflicting advice. Then we'll make up our own minds about "Who should take a daily aspirin."
Drugs - the legal kind that we get with a prescription, are fascinating. How do they work? Why to they work? Why do they sometimes not work very well? Why are some of them so expensive? In this podcast, we'll explore some of that. I've been teaching the science of drug therapy to medical and pharmacy students for 25 years and I've learned a few things along the way. Join me as we explore why Drugs (Sometimes) Work.
From the publisher's feed